Literature DB >> 16252240

Promoter and 3'-untranslated-region haplotypes in the vitamin d receptor gene predispose to osteoporotic fracture: the rotterdam study.

Yue Fang1, Joyce B J van Meurs, Arnold d'Alesio, Mila Jhamai, Hongyan Zhao, Fernando Rivadeneira, Albert Hofman, Johannes P T van Leeuwen, Frédéric Jehan, Huibert A P Pols, André G Uitterlinden.   

Abstract

Polymorphisms of the vitamin D receptor gene (VDR) have been shown to be associated with several complex diseases, including osteoporosis, but the mechanisms are unknown and study results have been inconsistent. We therefore determined sequence variation across the major relevant parts of VDR, including construction of linkage disequilibrium blocks and identification of haplotype alleles. We analyzed 15 haplotype-tagging SNPs in relation to 937 clinical fractures recorded in 6,148 elderly whites over a follow-up period of 7.4 years. Haplotype alleles of the 5' 1a/1e, 1b promoter region and of the 3' untranslated region (UTR) were strongly associated with increased fracture risk. For the 16% of subjects who had risk genotypes at both regions, their risk increased 48% for clinical fractures (P = .0002), independent of age, sex, height, weight, and bone mineral density. The population-attributable risk varied between 1% and 12% for each block and was 4% for the combined VDR risk genotypes. Functional analysis of the variants demonstrated 53% lower expression of a reporter construct with the 1e/1a promoter risk haplotype (P = 5 x 10(-7)) in two cell lines and 15% lower mRNA level of VDR expression constructs carrying 3'-UTR risk haplotype 1 in five cell lines (P = 2 x 10(-6)). In a further analysis, we showed 30% increased mRNA decay in an osteoblast cell line for the construct carrying the 3'-UTR risk haplotype (P = .02). This comprehensive candidate-gene analysis demonstrates that the risk allele of multiple VDR polymorphisms results in lower VDR mRNA levels. This could impact the vitamin D signaling efficiency and might contribute to the increased fracture risk we observed for these risk haplotype alleles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16252240      PMCID: PMC1271389          DOI: 10.1086/497438

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  36 in total

1.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

2.  Interaction between the vitamin D receptor gene and collagen type Ialpha1 gene in susceptibility for fracture.

Authors:  A G Uitterlinden; A E Weel; H Burger; Y Fang; C M van Duijn; A Hofman; J P van Leeuwen; H A Pols
Journal:  J Bone Miner Res       Date:  2001-02       Impact factor: 6.741

3.  Vitamin D receptor gene polymorphisms, particularly the novel A-1012G promoter polymorphism, are associated with vitamin D3 responsiveness and non-familial susceptibility in psoriasis.

Authors:  J A Halsall; J E Osborne; J H Pringle; P E Hutchinson
Journal:  Pharmacogenet Genomics       Date:  2005-05       Impact factor: 2.089

4.  The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene.

Authors:  H Arai; K I Miyamoto; M Yoshida; H Yamamoto; Y Taketani; K Morita; M Kubota; S Yoshida; M Ikeda; F Watabe; Y Kanemasa; E Takeda
Journal:  J Bone Miner Res       Date:  2001-07       Impact factor: 6.741

5.  Vitamin D receptor as a candidate tumor-suppressor gene in severe hyperparathyroidism of uremia.

Authors:  S B Brown; T T Brierley; N Palanisamy; I B Salusky; W Goodman; M L Brandi; T B Drüeke; E Sarfati; P Ureña; R S Chaganti; J W Pike; A Arnold
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

6.  A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality.

Authors:  V Mann; E E Hobson; B Li; T L Stewart; S F Grant; S P Robins; R M Aspden; S H Ralston
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

7.  Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk.

Authors:  Joyce B J van Meurs; Stephanie C E Schuit; Angélique E A M Weel; Marjolein van der Klift; Arjan P Bergink; Pascal P Arp; Edgar M Colin; Yue Fang; Albert Hofman; Cornelia M van Duijn; Johannes P T M van Leeuwen; Huibert A P Pols; André G Uitterlinden
Journal:  Hum Mol Genet       Date:  2003-07-15       Impact factor: 6.150

8.  The incidence of vertebral fractures in men and women: the Rotterdam Study.

Authors:  Marjolein Van der Klift; Chris E D H De Laet; Eugene V McCloskey; Albert Hofman; Huibert A P Pols
Journal:  J Bone Miner Res       Date:  2002-06       Impact factor: 6.741

9.  Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians.

Authors:  Babatunji-William Ogunkolade; Barbara J Boucher; Jean M Prahl; Stephen A Bustin; Jacky M Burrin; Kate Noonan; Bernard V North; Nassima Mannan; Michael F McDermott; Hector F DeLuca; Graham A Hitman
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

10.  Association of 3'-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease.

Authors:  J-C Lambert; E Luedecking-Zimmer; S Merrot; A Hayes; U Thaker; P Desai; A Houzet; X Hermant; D Cottel; A Pritchard; T Iwatsubo; F Pasquier; B Frigard; P M Conneally; M-C Chartier-Harlin; S T DeKosky; C Lendon; D Mann; M I Kamboh; P Amouyel
Journal:  J Med Genet       Date:  2003-06       Impact factor: 6.318

View more
  94 in total

1.  The -4817 G>A (rs2238136) variant of the vitamin D receptor gene: a probable risk factor for colorectal cancer.

Authors:  Touraj Mahmoudi; Maral Arkani; Khatoon Karimi; Akram Safaei; Fatemeh Rostami; Elham Arbabi; Mohamad Amin Pourhoseingholi; Seyed Reza Mohebbi; Abdolrahim Nikzamir; Sara Romani; Shohreh Almasi; Maryam Abbaszadeh; Mohammad Vafaei; Mohammad Reza Zali
Journal:  Mol Biol Rep       Date:  2011-12-14       Impact factor: 2.316

2.  Genetics of the bone response to bisphosphonate treatments.

Authors:  Francesco Massart; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2009-01

3.  Common allelic variants of the vitamin receptor D gene rs7975232 (ApaI) do not influence bone mineral density figures in postmenopausal osteoporotic women.

Authors:  Maria Pedrera-Canal; Jose M Moran; Vicente Vera; Raul Roncero-Martin; Jesus M Lavado-Garcia; Ignacio Aliaga; Juan D Pedrera-Zamorano
Journal:  Int J Clin Exp Med       Date:  2015-05-15

4.  Association of vitamin D receptor gene polymorphisms with disc degeneration.

Authors:  Adam Biczo; Julia Szita; Iain McCall; Peter Pal Varga; Aron Lazary
Journal:  Eur Spine J       Date:  2019-11-25       Impact factor: 3.134

Review 5.  A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Hum Genet       Date:  2006-06-29       Impact factor: 4.132

6.  Robust and comprehensive analysis of 20 osteoporosis candidate genes by very high-density single-nucleotide polymorphism screen among 405 white nuclear families identified significant association and gene-gene interaction.

Authors:  Dong-Hai Xiong; Hui Shen; Lan-Juan Zhao; Peng Xiao; Tie-Lin Yang; Yan Guo; Wei Wang; Yan-Fang Guo; Yong-Jun Liu; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2006-11       Impact factor: 6.741

7.  A common NOS1AP genetic polymorphism is associated with increased cardiovascular mortality in users of dihydropyridine calcium channel blockers.

Authors:  Matthijs L Becker; Loes E Visser; Christopher Newton-Cheh; Albert Hofman; André G Uitterlinden; Jacqueline C M Witteman; Bruno H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2008-11-17       Impact factor: 4.335

8.  Vitamin D Receptor Polymorphisms Are Associated with Reduced Esophageal Vitamin D Receptor Expression and Reduced Esophageal Adenocarcinoma Risk.

Authors:  Vincent T Janmaat; Anouk Van De Winkel; Maikel P Peppelenbosch; Manon C W Spaander; André G Uitterlinden; Farzin Pourfarzad; Hugo W Tilanus; Agnieszka M Rygiel; Leon M G Moons; Pascal P Arp; Kausilia K Krishnadath; Ernst J Kuipers; Luc J W Van Der Laan
Journal:  Mol Med       Date:  2015-04-21       Impact factor: 6.354

9.  Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men.

Authors:  Marian T Hannan; Heather J Litman; Andre B Araujo; Christine E McLennan; Robert R McLean; John B McKinlay; Tai C Chen; Michael F Holick
Journal:  J Clin Endocrinol Metab       Date:  2007-11-06       Impact factor: 5.958

10.  Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia.

Authors:  Mariël L te Winkel; Robert D van Beek; Sabine M P F de Muinck Keizer-Schrama; André G Uitterlinden; Wim C J Hop; Rob Pieters; Marry M van den Heuvel-Eibrink
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.